Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06958250 · ClinicalTrials.gov registry record · NA
Novel Endoscopic Bite Block
A NA study of Gastric Disease, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06958250: Recruiting NA study of Gastric Disease, sponsored by University of Pennsylvania.
NCT06958250 is a NA study of Gastric Disease that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06958250, a NA study of Gastric Disease, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This feasibility study aims to assess the safety and effectiveness of the Novel Endoscopic Bite Block. The device will be utilized in subjects undergoing routine outpatient upper endoscopy. The investigator hypothesizes that its innovative design will reduce complications associated with bite block positioning, thereby improving procedural efficiency and patient safety.
Primary Outcome
Proportion of endoscopic procedures that are successfully completed
Conditions Studied
Interventions
- DEVICE Novel Bite Block
Study Locations (1)
New Jersey
- Penn Medicine Princeton Health - Plainsboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-12-22 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06958250 shows while recruiting
NCT06958250 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Gastric Disease appearing as the primary indexed condition, and to 1 intervention - of which Novel Bite Block is the first listed.
NCT06958250 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06958250 about?
NCT06958250 is a clinical study titled "Novel Endoscopic Bite Block". This feasibility study aims to assess the safety and effectiveness of the Novel Endoscopic Bite Block. The device will be utilized in subjects undergoing routine outpatient upper endoscopy. The investigator hypothesizes that its innovative design will reduce complications associated with bite block ...
What is the current status of trial NCT06958250?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-12-22. Estimated completion is 2026-12.
What conditions does trial NCT06958250 study?
This clinical trial studies the following conditions: Gastric Disease.
What interventions are being tested in trial NCT06958250?
The interventions under investigation include: Novel Bite Block (DEVICE).
Who is sponsoring clinical trial NCT06958250?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06958250 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastric Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06958250's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI